Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.

@article{Ramalho2002FivePO,
  title={Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.},
  author={A. Ramalho and S. Beck and M. Meyer and D. Penque and G. Cutting and M. Amaral},
  journal={American journal of respiratory cell and molecular biology},
  year={2002},
  volume={27 5},
  pages={
          619-27
        }
}
  • A. Ramalho, S. Beck, +3 authors M. Amaral
  • Published 2002
  • Biology, Medicine
  • American journal of respiratory cell and molecular biology
  • Estimates of the level of transcripts from the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene required to develop a CF phenotype range from 4-20% of normal. Due to the importance of obtaining reliable data on this issue for therapeutic strategies, we developed a novel polymerase chain reaction-based method to quantify CFTR transcripts and applied it to the analysis of nasal epithelium RNA of five patients with CF and the 3272-26A>G/F508del genotype. We calculated that 8.2… CONTINUE READING
    164 Citations

    Figures, Tables, and Topics from this paper

    Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.
    • 52
    Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.
    • 33
    • PDF
    The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.
    • 6
    CFTR and Cystic Fibrosis: From Structure to Function
    • 1
    What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect
    • 80

    References

    SHOWING 1-10 OF 48 REFERENCES
    The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.
    • 162